Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysis

被引:9
作者
Chen, Hong-Lin [1 ]
Chen, Yu-Hua [2 ]
Du, Lin [1 ]
Song, Yi-Ping [1 ]
Zhu, Bin [3 ]
机构
[1] Nantong Univ, Sch Publ Hlth, Nantong City, Jiangsu, Peoples R China
[2] Nantong Hlth Coll Jiangsu Prov, Nantong City, Jiangsu, Peoples R China
[3] Nantong Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, Nantong City, Jiangsu, Peoples R China
关键词
Hepatocellular carcinoma; Surgical resection; Alpha-fetoproteins; Prognosis; INFLAMMATION INDEX PREDICTS; LIVER RESECTION; HEPATIC-RESECTION; CURATIVE RESECTION; INTRAHEPATIC RECURRENCE; RISK-FACTORS; TRANSARTERIAL CHEMOEMBOLIZATION; BETA2-ADRENERGIC RECEPTOR; CLINICAL CHARACTERISTICS; ANATOMICAL RESECTION;
D O I
10.1016/j.ajg.2020.09.004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and study aims: The relationship between the alpha-fetoprotein (AFP) level and the prognosis of hepatocellular carcinoma (HCC) after surgical resection remains unknown. This study aims to assess this relationship. Patients and methods: PubMed and Web of Science were systematically utilised. Meta-analysis was conducted for the outcomes of the recurrence-free survival (RFS) and the overall survival (OS) by comparing the high AFP group with the low AFP group. Results: The studies included 61 manuscripts with 35,461 patients. The summary hazard ratio (HR) for RFS was 1.501 (95% CI 1.355-1.662; Z = 7.81, P < 0.00001) when comparing the high AFP group with the low AFP group. Sensitivity analysis only included adjusted HRs, with the summary HR being 1.563 (95% CI 1.381-1.768; Z = 7.10, P < 0.00001). The summary HR for OS was 1.565 (95% CI 1.439-1.701; Z = 10.52, P < 0.00001) when comparing two AFP groups. Sensitivity analysis showed that the summary HR was 1.611 (95% CI 1.456-1.782; Z = 9.24, P < 0.00001). Conclusion: Our meta-analysis indicated that elevated serum AFP levels are associated with poor prognosis of HCC after surgical resection. (C) 2020 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 22
页数:11
相关论文
共 83 条
[1]   Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy [J].
Andreou, Andreas ;
Vauthey, Jean-Nicolas ;
Cherqui, Daniel ;
Zimmitti, Giuseppe ;
Ribero, Dario ;
Truty, Mark J. ;
Wei, Steven H. ;
Curley, Steven A. ;
Laurent, Alexis ;
Poon, Ronnie T. ;
Belghiti, Jacques ;
Nagorney, David M. ;
Aloia, Thomas A. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (01) :66-77
[2]  
Bai K., 2016, Medicine, V95
[3]  
Benzoni E, 2007, TUMORI J, V93, P264
[4]   Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: Serum sodium predicts survival [J].
Biolato, Marco ;
Miele, Luca ;
Vero, Vittoria ;
Racco, Simona ;
Di Stasi, Carmine ;
Iezzi, Roberto ;
Zanche, Andrea ;
Pompili, Maurizio ;
Rapaccini, Gian Ludovico ;
La Torre, Giuseppe ;
Gasbarrini, Antonio ;
Grieco, Antonio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (25) :8158-8165
[5]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[6]  
Byeon Jangmoo, 2012, Korean J Hepatobiliary Pancreat Surg, V16, P93, DOI 10.14701/kjhbps.2012.16.3.93
[7]   Predictors and patterns of recurrence after resection of hepatocellular carcinoma [J].
Cha, C ;
Fong, YM ;
Jarnagin, WR ;
Blumgart, LH ;
DeMatteo, RP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :753-758
[8]   The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection [J].
Chen, Dongtai ;
Xing, Wei ;
Hong, Jian ;
Wang, Meibing ;
Huang, Yang ;
Zhu, Cuizhen ;
Yuan, Yunfei ;
Zeng, Weian .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) :3556-3565
[9]   Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection [J].
Chen, JY ;
Chau, GY ;
Lui, WY ;
Tsay, SH ;
King, KL ;
Wu, CW .
WORLD JOURNAL OF SURGERY, 2003, 27 (03) :294-298
[10]   Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection [J].
Fu, Shun-Jun ;
Qi, Chao-Ying ;
Xiao, Wei-Kai ;
Li, Shao-Qiang ;
Peng, Bao-Gang ;
Liang, Li-Jian .
SURGERY, 2013, 154 (03) :536-544